Stocks
IGM Biosciences (IGMS) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -40.8 | -77.8 | -157.4 | -221.9 | -253.4 | -226.3 | ||
| Changes by years, y/y, % | +81% | +91% | +102% | +41% | +14% | +62.3% | |||
IGM Biosciences. EBITDA US GAAP, bln rub
IGM Biosciences. EBITDA US GAAP, changes, %
IGM Biosciences. EBITDA US GAAP, sum by quarters, bln rub
IGM Biosciences (IGMS) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -64.5 | -63.4 | -51.7 | -49.1 | -62.1 | -226.3 | |
| Changes by years, y/y, % | +9% | +13% | -16% | -26% | -4% | |||
| Changes by quarters, q/q, % | -2% | -2% | -19% | -5% | +26% | |||
